187 related articles for article (PubMed ID: 27169446)
41. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
42. Acquired Aplastic Anemia as a Clonal Disorder of Hematopoietic Stem Cells.
Brzeźniakiewicz-Janus K; Rupa-Matysek J; Gil L
Stem Cell Rev Rep; 2020 Jun; 16(3):472-481. PubMed ID: 32270433
[TBL] [Abstract][Full Text] [Related]
43. Clinical spectrum and clonal evolution in germline syndromes with predisposition to myeloid neoplasms.
Perez Botero J; Ho TP; Hogan WJ; Kenderian S; Gangat N; Tefferi A; Abraham RS; Nguyen P; Oliveira JL; He R; Chen D; Viswanatha D; Rodriguez V; Khan SP; Patnaik MM
Br J Haematol; 2018 Jul; 182(1):141-145. PubMed ID: 28485484
[No Abstract] [Full Text] [Related]
44. Clonal evolution and clinical significance of copy number neutral loss of heterozygosity of chromosome arm 6p in acquired aplastic anemia.
Betensky M; Babushok D; Roth JJ; Mason PJ; Biegel JA; Busse TM; Li Y; Lind C; Papazoglou A; Monos D; Podsakoff G; Bessler M; Olson TS
Cancer Genet; 2016; 209(1-2):1-10. PubMed ID: 26702937
[TBL] [Abstract][Full Text] [Related]
45. Special Education: Aplastic Anemia.
Teramura M; Mizoguchi H
Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
[TBL] [Abstract][Full Text] [Related]
46. Comparison of long-term outcomes between children with aplastic anemia and refractory cytopenia of childhood who received immunosuppressive therapy with antithymocyte globulin and cyclosporine.
Hama A; Takahashi Y; Muramatsu H; Ito M; Narita A; Kosaka Y; Tsuchida M; Kobayashi R; Ito E; Yabe H; Ohga S; Ohara A; Kojima S
Haematologica; 2015 Nov; 100(11):1426-33. PubMed ID: 26273061
[TBL] [Abstract][Full Text] [Related]
47. Histological and cytogenetic characterization of bone marrow in relation to prognosis and diagnosis of myelodysplastic syndromes.
Sakuma T; Hayashi Y; Kanomata N; Murayama T; Matsui T; Kajimoto K; Hanioka K; Chihara K; Maeda S
Pathol Int; 2006 Apr; 56(4):191-9. PubMed ID: 16634964
[TBL] [Abstract][Full Text] [Related]
48. Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemia.
Groarke EM; Patel BA; Shalhoub R; Gutierrez-Rodrigues F; Desai P; Leuva H; Zaimoku Y; Paton C; Spitofsky N; Lotter J; Rios O; Childs RW; Young DJ; Dulau-Florea A; Dunbar CE; Calvo KR; Wu CO; Young NS
Leukemia; 2022 Sep; 36(9):2328-2337. PubMed ID: 35896822
[TBL] [Abstract][Full Text] [Related]
49. The formation of a somatic mutation in the HLA-B gene throughout the development of the disease from severe aplastic anaemia to acute myeloid leukaemia.
Jana N; Milena V; Eva R; Sara N; Šárka P; Cyril Š; Pietro C; Jana B; Monika B; Evangelista DJ
HLA; 2019 Dec; 94 Suppl 2():30-33. PubMed ID: 31733047
[TBL] [Abstract][Full Text] [Related]
50. Karyotype instability in myelodysplastic syndromes--a specific step in pathogenesis preceding clonal chromosome anomalies.
Haase D; Fonatsch C; Freund M
Leuk Lymphoma; 1992 Oct; 8(3):221-8. PubMed ID: 1490148
[TBL] [Abstract][Full Text] [Related]
51. Quantitative analysis of bone marrow CD34 cells in aplastic anemia and hypoplastic myelodysplastic syndromes.
Matsui WH; Brodsky RA; Smith BD; Borowitz MJ; Jones RJ
Leukemia; 2006 Mar; 20(3):458-62. PubMed ID: 16437138
[TBL] [Abstract][Full Text] [Related]
52. Origins of myelodysplastic syndromes after aplastic anemia.
Negoro E; Nagata Y; Clemente MJ; Hosono N; Shen W; Nazha A; Yoshizato T; Hirsch C; Przychodzen B; Mahfouz RZ; Kuzmanovic T; Sekeres MA; Makishima H; Ogawa S; Maciejewski JP
Blood; 2017 Oct; 130(17):1953-1957. PubMed ID: 28893734
[No Abstract] [Full Text] [Related]
53. The evidence of clonal evolution with monosomy 7 in aplastic anemia following granulocyte colony-stimulating factor using the polymerase chain reaction.
Yamazaki E; Kanamori H; Taguchi J; Harano H; Mohri H; Okubo T
Blood Cells Mol Dis; 1997 Aug; 23(2):213-8. PubMed ID: 9236159
[TBL] [Abstract][Full Text] [Related]
54. Hypoplastic myelodysplastic syndrome (h-MDS) is a distinctive clinical entity with poorer prognosis and frequent karyotypic and FISH abnormalities compared to aplastic anemia (AA).
Koh Y; Lee HR; Song EY; Kim HK; Kim I; Park S; Park MH; Kim BK; Yoon SS; Lee DS
Leuk Res; 2010 Oct; 34(10):1344-50. PubMed ID: 20427085
[TBL] [Abstract][Full Text] [Related]
55. p53 expression in myeloid cells of myelodysplastic syndromes. Association with evolution of overt leukemia.
Kitagawa M; Yoshida S; Kuwata T; Tanizawa T; Kamiyama R
Am J Pathol; 1994 Aug; 145(2):338-44. PubMed ID: 8053492
[TBL] [Abstract][Full Text] [Related]
56. Analysis of abnormal clones by the fluorescent aerolysin method in paroxysmal nocturnal haemoglobinuria and other marrow disorders.
Agarwal R; Chapple P; Brown M; Szer J; Juneja S
Int J Lab Hematol; 2015 Feb; 37(1):14-21. PubMed ID: 24702736
[TBL] [Abstract][Full Text] [Related]
57. Next-Generation Gene Sequencing Differentiates Hypoplastic Myelodysplastic Syndrome from Aplastic Anemia.
Lew JL; Fenderson JL; Carmichael MG
Hawaii J Med Public Health; 2017 Nov; 76(11 Suppl 2):10-12. PubMed ID: 29164009
[TBL] [Abstract][Full Text] [Related]
58. Clonal dynamics of hematopoietic stem cell compartment in aplastic anemia.
Visconte V; Maciejewski JP
Semin Hematol; 2022 Jan; 59(1):47-53. PubMed ID: 35491059
[TBL] [Abstract][Full Text] [Related]
59. Application of the molecular analysis of the T-cell receptor repertoire in the study of immune-mediated hematologic diseases.
Plasilova M; Risitano A; Maciejewski JP
Hematology; 2003 Jun; 8(3):173-81. PubMed ID: 12745651
[TBL] [Abstract][Full Text] [Related]
60. Overview: A New Era of Cancer Genome in Myeloid Malignancies.
Kiyoi H
Oncology; 2015; 89 Suppl 1():1-3. PubMed ID: 26551625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
